Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 22. August 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9044  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180880  
   
Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan.
Eur Urol Focus
Sciarra A, Casale P, Bevilacqua G, Basile G, Santarelli V, Buffi NM, Lazzeri M, Lunghezzani G, Lucciola S, Messina E, Laschena L, Dehghanpour A, Di Pierro GB, Franco G, Del Giudice F, Gentilucci A, Dipinto P, Corvino R, Salciccia S, Magliocca FM, Panebianco V.
PMID: 42629306 [PubMed - as supplied by publisher]


No Evidence of Post-Finasteride Syndrome in 267,983 person-years follow-up in the Prostate Cancer Prevention Trial.
Urology
Till C, Tangen CM, Goodman P, Unger JM, Thompson IM Jr.
PMID: 42628582 [PubMed - as supplied by publisher]


Age at Diagnosis and Postoperative Outcomes Among Men Treated for Prostate Cancer in the U.S. Military Health System.
Clin Genitourin Cancer
Oroho MR, Dide-Agossou C, Kern SQ, Almeida AA, Darmon S, Shriver CD, Zhu K, Eaglehouse YL.
PMID: 42628214 [PubMed - as supplied by publisher]


APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
JCO Precis Oncol
Shi X, Shetty AC, Wang J, Song Y, Sutera PA, Deek MP, Patel KR, Madan RA, Tang C, Proudfoot J, Davicioni E, Hussain A, Nguyen P, Sweeney C, Boytim E, Lacuna KP, Ryan CJ, Antonarakis ES, Tran PT, Hwang J.
PMID: 42628007 [PubMed - indexed for MEDLINE]


Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Clin Cancer Res
Zacharias NM, Rupe ES, Chen X, Kotecha RR, Rieke DT, McGregor BA, Pesquera P, Yu Z, Grover A, Daw NC, Wang E, Chan SWS, Douglas-Lindsay D, Fan AC, Knoche EM, Kyriakopoulos CE, Lalani AA, Mantia CM, Merla A, Voss MH, Pfanzelter N, Ramakrishna S, Reaume NM, Tang T, Ingram DR, Shamsutdinova D, Wani KM, Wang WL, Lazar AJ, Sheth RA, Rao P, Grimm SL, Coarfa C, He R, Qian J, Duan F, Bisht D, Chauhan PK, Perelli L, Genovese G, Yang L, Lin C, Karam JA, La Posta L, Dondossola E, Basar R, Uprety N, Rezvani K, Gao J, Wang L, Solis Soto LM, Lim B, Tannir NM, Karki M, Msaouel P.
PMID: 42627757 [PubMed - as supplied by publisher]


ASO Visual Abstract: A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study.
Ann Surg Oncol
Zhu Y, Ge L, Liu Z, Sun J, Wang X, Chu C, Zhao Z, Zhu Z, Shen H, Shi J, Liu G, Ji C, Zhang Q, Gan W, Zhang S, Jiang B, Guo H.
PMID: 42627609 [PubMed - as supplied by publisher]


Adjunctive topical hemostatic agents combined with renorrhaphy versus renorrhaphy alone during partial nephrectomy: a systematic review and meta-analysis.
World J Urol
Shiomi da Cruz JA, De Souza Almeida A, Terada BD, Gonçalves FGA, Porto BC, Da Silva Sardenberg RA, Silva TA, Soares Maia R, de Almeida FG, de Almeida Luz M.
PMID: 42627530 [PubMed - indexed for MEDLINE]


Fruit and vegetable consumption, dietary and plasma carotenoids and risks of recurrence and progression in patients with non-muscle-invasive bladder cancer.
Eur J Nutr
Vrieling A, Kiebach J, Balvers M, Aben KK, van der Heijden AG, Kampman E, Kiemeney LA.
PMID: 42627386 [PubMed - indexed for MEDLINE]


The impact of intraoperative ureteral stent omission on postoperative complications during radical cystectomy.
World J Urol
Pfail J, O'Leary C, Fu M, Kaldany A, Chua K, Passarelli R, Lichtbroun B, Patel H, Srivastava A, Golombos D, Jang TL, Packiam VT, Ghodoussipour S.
PMID: 42627381 [PubMed - indexed for MEDLINE]


Designing, psychometric, and application of measurement instrument for Self-Care Literacy in Prevention of Prostate Cancer (SCL-PCa): A mixed-method study protocol.
J Educ Health Promot
Ramezankhani A, Razaghi MR, Kavousi A, Marashi T, Moradi A.
PMID: 42626712 [PubMed]


Single-cell and spatial omics of metabolic-immune ecosystems in prostate cancer: from androgen signaling to therapy resistance.
Front Immunol
Wang R, Li Y, Wang X.
PMID: 42626336 [PubMed - indexed for MEDLINE]


Updated oncolytic viruses for the treatment of bladder cancer: a systematic review.
Iran J Microbiol
Khatami F, Mohammadi A, Azadmanesh K, Deyhimfar R, Ghajar HA, Nikoofar P, Aghamir SMK.
PMID: 42625927 [PubMed]


The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients With Bladder Cancer: A Meta-Analysis.
Clin Med Insights Oncol
Shi Y, Luo X, Huang Y, Tan C, Liu J.
PMID: 42625803 [PubMed]


Multimodal deep learning for prediction of postoperative recurrence in clear cell renal cell carcinoma: a clinical-radiologic-pathologic approach.
Front Oncol
Yang Y, Wu J, Shi F, Ren Q, Gao P, Meng X.
PMID: 42625638 [PubMed]


Comparative outcomes of robot-assisted and open radical nephrectomy with inferior vena cava thrombectomy for renal cell carcinoma: a systematic review and meta-analysis.
J Robot Surg
Ma XD, Chen SY, Yang JW, Wang L, Dong ZL, Yang L.
PMID: 42624966 [PubMed - indexed for MEDLINE]


Re: Contieri R, Paciotti M, Uleri A, et al. Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol. 2026;9:404-412.
Eur Urol Oncol
Scarpa RM.
PMID: 42624768 [PubMed - as supplied by publisher]


PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study.
J Nucl Med
Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin J, Calais J.
PMID: 42624652 [PubMed - as supplied by publisher]


The emerging trends in prostate cancer treatment: a systematic review of the literature.
J Chemother
Fatima SA, Haider KH, Qutubuddin S, Begum Y, Stevenson M, Fatima K, Anwar EI, Barg M.
PMID: 42624527 [PubMed - as supplied by publisher]


Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications-A Systematic Review.
Clin Genitourin Cancer
Posite CM, Wabinga H, Atwine R, Vahwere BM, Mitamo AA, Hakizimana T, Kiswezi A, Archibong VB, Usman IM.
PMID: 42624022 [PubMed - as supplied by publisher]


Best evidence summary for non-pharmacological management of cancer-related fatigue in patients with prostate cancer.
Geriatr Nurs
Jiang M, Xu M, Chen Q, Fu X, Lin X, Chen X.
PMID: 42623906 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 180880    Seite 1 von 9044  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1